These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

719 related items for PubMed ID: 16621899

  • 1. Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice.
    Schertzer JD, Ryall JG, Lynch GS.
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E499-505. PubMed ID: 16621899
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1.
    De Luca A, Pierno S, Liantonio A, Cetrone M, Camerino C, Fraysse B, Mirabella M, Servidei S, Rüegg UT, Conte Camerino D.
    J Pharmacol Exp Ther; 2003 Jan; 304(1):453-63. PubMed ID: 12490622
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. IGF-II ameliorates the dystrophic phenotype and coordinately down-regulates programmed cell death.
    Smith J, Goldsmith C, Ward A, LeDieu R.
    Cell Death Differ; 2000 Nov; 7(11):1109-18. PubMed ID: 11139285
    [Abstract] [Full Text] [Related]

  • 11. Dystrophin deficiency in canine X-linked muscular dystrophy in Japan (CXMDJ) alters myosin heavy chain expression profiles in the diaphragm more markedly than in the tibialis cranialis muscle.
    Yuasa K, Nakamura A, Hijikata T, Takeda S.
    BMC Musculoskelet Disord; 2008 Jan 09; 9():1. PubMed ID: 18182116
    [Abstract] [Full Text] [Related]

  • 12. Systemic administration of L-arginine benefits mdx skeletal muscle function.
    Barton ER, Morris L, Kawana M, Bish LT, Toursel T.
    Muscle Nerve; 2005 Dec 09; 32(6):751-60. PubMed ID: 16116642
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparative evaluation of IGF-I gene transfer and IGF-I protein administration for enhancing skeletal muscle regeneration after injury.
    Schertzer JD, Lynch GS.
    Gene Ther; 2006 Dec 09; 13(23):1657-64. PubMed ID: 16871234
    [Abstract] [Full Text] [Related]

  • 18. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice.
    Montgomery E, Pennington C, Isales CM, Hamrick MW.
    Anat Rec A Discov Mol Cell Evol Biol; 2005 Sep 09; 286(1):814-22. PubMed ID: 16078270
    [Abstract] [Full Text] [Related]

  • 19. Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice.
    Lochmüller H, Petrof BJ, Pari G, Larochelle N, Dodelet V, Wang Q, Allen C, Prescott S, Massie B, Nalbantoglu J, Karpati G.
    Gene Ther; 1996 Aug 09; 3(8):706-16. PubMed ID: 8854096
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.